iSERA Lifesciences Share Price
143.90+0.00 (+0.00%)
+2367.74% past 1 Year
Aptus Industries Limited is a Public Limited Company and engaged in handling of Agricultural Software Construction and Infrastructure Projects. They were incorporated in 27th January 1993. They are located in
Corporate filings & documents
Announcements
iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.
2 days agoiSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.
2 days agoWe hereby informed that Board of Directors of the Company at its meeting held on Tuesday the 01st September 2026 discuss the agenda attached herewith.
3 days agoWe hereby informed that Board of Directors of the Company at its meeting held on Tuesday the 01st September 2026 discuss the agenda attached herewith.
3 days agoWe hereby submit the monitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended June 30 2026.
2 weeks agoWe are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
4 weeks agoWe are hereby submitting the Unaudited Financial Results of the Company for the quarter ended June 30 2026.
4 weeks agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Friday the 07th day of August 2026 at the Registered Office of the Company which commenced at 02:00 P.M.and concluded at 02:30 P.M. considered and approved inter alia to approve the Un-Audited Financial Results of the Company for the quarter ended June 30 2026.
4 weeks agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Friday the 07th day of August 2026 at the Registered Office of the Company which commenced at 02:00 P.M.and concluded at 02:30 P.M. considered and approved inter alia to approve the Un-Audited Financial Results of the Company for the quarter ended June 30 2026.
4 weeks agoIsera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended on June 30 2026
1 month agoIsera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended on June 30 2026
1 month agoWe are hereby submitting the Certificate issued by Share Transfer Agent of the Company confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on 30th June 2026.
1 month agoWe are hereby submitting the Certificate issued by Share Transfer Agent of the Company confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended on 30th June 2026.
1 month agoScrutinizers Report and Voting Results of the Re-opened Postal Ballot (Remote E-Voting) conducted pursuant to the Corrigendum to the Postal Ballot Notice dated June 26 2026.
2 months agoScrutinizers Report and Voting Results of the Re-opened Postal Ballot (Remote E-Voting) conducted pursuant to the Corrigendum to the Postal Ballot Notice dated June 26 2026.
2 months agoSubmission of Newspaper Advertisement of Corrigendum to the Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
2 months agoSubmission of Newspaper Advertisement of Corrigendum to the Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
2 months agoWe wish to inform you that iSERA Lifesciences Limited (Formerly known as Covidh TechnologiesLimited) has issued a Corrigendum to the Notice of Postal Ballot dated April 21 2026 videCorrigendum dated June 26 2026 in connection with the proposed preferential issue of equity shares forconsideration other than cash (Share Swap). The said Corrigendum has been dispatched to all Members ofthe Company as on the cut-off date i.e. Friday April 17 2026 on June 26 2026.A copy of the Corrigendum is enclosed herewith for your kind perusal and records.Kindly take the above on record.
2 months agoWe wish to inform you that iSERA Lifesciences Limited (Formerly known as Covidh TechnologiesLimited) has issued a Corrigendum to the Notice of Postal Ballot dated April 21 2026 videCorrigendum dated June 26 2026 in connection with the proposed preferential issue of equity shares forconsideration other than cash (Share Swap). The said Corrigendum has been dispatched to all Members ofthe Company as on the cut-off date i.e. Friday April 17 2026 on June 26 2026.A copy of the Corrigendum is enclosed herewith for your kind perusal and records.Kindly take the above on record.
2 months agoWe are hereby submitting the Closure of Trading Window for the Quarter June 30 2026.
2 months agoWe are hereby submitting the Closure of Trading Window for the Quarter June 30 2026.
2 months agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as "Covidh Technologies Limited") was held on Wednesday June 11 2026. The following businesses were transacted at the aforesaid Board Meeting:
2 months agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as "Covidh Technologies Limited") was held on Wednesday June 11 2026. The following businesses were transacted at the aforesaid Board Meeting:
2 months agoWe hereby submit the Newspaper Advertisement for the financial result for the year and quarter ended March 31 2026
3 months agoWe hereby submit the Newspaper Advertisement for the financial result for the year and quarter ended March 31 2026
3 months agoWe are hereby submitting the Scrutinizers Report for the postal ballot.
3 months agoWe hereby submit the declaration w.r.t. non applicability of regulation 23(9) of SEBI LODR
3 months agoWe hereby submit the declaration w.r.t. non applicability of regulation 23(9) of SEBI LODR
3 months agoRevised outcome of the board meeting for discussing and approving the financial results for the year ended 31.03.2026
3 months agoRevised outcome of the board meeting for discussing and approving the financial results for the year ended 31.03.2026
3 months agoWe hereby Submitted the Financial Result for the Financial Year ended 31 March 2026
3 months agoWe hereby submitted Pursuant to the provisions of Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Thursday the 21st day of May 2026 held via video conferencing which commenced at 07:00 P.M. and concluded at 07:40 P.M. considered and approved inter-alia: 1. The Audited Financial Results (Standalone) for the Quarter and year ended 31st March 2026 in pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.2. Independent Auditors Report on Audited Financial Results (Standalone) of the Company for the quarter and year ended 31st March 2026.3. Declaration for unmodified opinion in terms of Regulation 33(3)(d) as amended by SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations 2016 for Audited Standalone Financial Results for the year ended on 31st March 2026.
3 months agoWe hereby submitted Pursuant to the provisions of Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Thursday the 21st day of May 2026 held via video conferencing which commenced at 07:00 P.M. and concluded at 07:40 P.M. considered and approved inter-alia: 1. The Audited Financial Results (Standalone) for the Quarter and year ended 31st March 2026 in pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.2. Independent Auditors Report on Audited Financial Results (Standalone) of the Company for the quarter and year ended 31st March 2026.3. Declaration for unmodified opinion in terms of Regulation 33(3)(d) as amended by SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations 2016 for Audited Standalone Financial Results for the year ended on 31st March 2026.
3 months agoiSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited)has filed with exchange monitoring agency report for quarter ended March 31 2026.
3 months agoMonitoring Agency Report for utilization of proceeds of Rights Issue of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the quarter ended 31 March 2026.
3 months agoCovidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended on March 31 2026
3 months agoCovidh Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended on March 31 2026
3 months agoSubmission of Newspaper Advertisement of Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
4 months agoSubmission of Newspaper Advertisement of Postal Ballot Notice pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
4 months agoPursuant to the resolution passed by the Board of Directors of the Company at its meeting held on Tuesday April 21 2026 the Company encloses herewith the Postal Ballot Notice dated April 21 2026 seeking the approval of the Members of the Company by way of Postal Ballot / Remote E-Voting on the following matters
4 months agoRevised Outcome of the Meeting of the Board of Directors of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) (the Company) pursuant to Regulation 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
4 months agoISSUANCE OF EQUITY SHARES BY WAY OF PREFERENTIAL ISSUE ON PRIVATE PLACEMENT BASIS FOR CONSIDERATION OTHER THAN CASH (SHARE SWAP)
4 months agoISSUANCE OF EQUITY SHARES BY WAY OF PREFERENTIAL ISSUE ON PRIVATE PLACEMENT BASIS FOR CONSIDERATION OTHER THAN CASH (SHARE SWAP)
4 months agoThe Board of Directors considered and approved the increase in the Authorised Share Capital of the Company from Rs. 11 00 00 000/- (Rupees Eleven Crore Only) divided into 1 10 00 000 (One Crore Ten Lakh) Equity Shares of Rs. 10/- (Rupees Ten Only) each to Rs. 25 00 00 000/- (Rupees Twenty-Five Crore Only) divided into 2 50 00 000 (Two Crore Fifty Lakh) Equity Shares of Rs. 10/- (Rupees Ten Only) each by creation of 1 40 00 000 (One Crore Forty Lakh) additional Equity Shares of Rs. 10/- (Rupees Ten Only) each and the consequential alteration of Clause V of the Memorandum of Association of the Company subject to the approval of the Members of the Company by way of an Ordinary Resolution through Postal Ballot / Remote E-Voting pursuant to Section 110 of the Companies Act 2013 read with Rule 22 of the Companies (Management and Administration) Rules 2014.
4 months agoThe Board of Directors considered and approved the increase in the Authorised Share Capital of the Company from Rs. 11 00 00 000/- (Rupees Eleven Crore Only) divided into 1 10 00 000 (One Crore Ten Lakh) Equity Shares of Rs. 10/- (Rupees Ten Only) each to Rs. 25 00 00 000/- (Rupees Twenty-Five Crore Only) divided into 2 50 00 000 (Two Crore Fifty Lakh) Equity Shares of Rs. 10/- (Rupees Ten Only) each by creation of 1 40 00 000 (One Crore Forty Lakh) additional Equity Shares of Rs. 10/- (Rupees Ten Only) each and the consequential alteration of Clause V of the Memorandum of Association of the Company subject to the approval of the Members of the Company by way of an Ordinary Resolution through Postal Ballot / Remote E-Voting pursuant to Section 110 of the Companies Act 2013 read with Rule 22 of the Companies (Management and Administration) Rules 2014.
4 months agoThe Board of Directors considered and approved the acquisition of equity shares representing up to 100% of the paid-up equity share capital of iSERA Biological Limited (an unlisted public company CIN: U85300PN2016PLC165483) comprising up to 1 61 82 800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) equity shares of face value Rs. 10/- (Rupees Ten Only) each from the existing shareholders of iSERA Biological Limited for a total consideration of Rs. 78 00 10 960/- (Rupees Seventy-Eight Crore Ten Thousand Nine Hundred and Sixty Only) to be discharged entirely by way of issuance and allotment of up to 1 61 82 800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) fully paid-up equity shares of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited)
4 months agoThe Board of Directors considered and approved the acquisition of equity shares representing up to 100% of the paid-up equity share capital of iSERA Biological Limited (an unlisted public company CIN: U85300PN2016PLC165483) comprising up to 1 61 82 800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) equity shares of face value Rs. 10/- (Rupees Ten Only) each from the existing shareholders of iSERA Biological Limited for a total consideration of Rs. 78 00 10 960/- (Rupees Seventy-Eight Crore Ten Thousand Nine Hundred and Sixty Only) to be discharged entirely by way of issuance and allotment of up to 1 61 82 800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) fully paid-up equity shares of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited)
4 months agoPursuant to our prior intimation dated April 15 2026 and deferment intimation dated April 20 2026 and in terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations) read with SEBI Master Circular No. HO/49/14/14(7)/2025-CFD-POD2/I/3762/2026 dated January 30 2026 we wish to inform you that the Meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as Covidh Technologies Limited) (the Company) was held today i.e. Tuesday April 21 2026 at the Registered Office of the Company situated at Office No. A1-1202 12th Floor Boulevard Tower Phase-2 CTS No. 11 Sadhu Vaswani Chowk Camp Pune - 411001 Maharashtra wherein the Board of Directors inter alia considered and approved the following matters:
4 months agoPursuant to our prior intimation dated April 15 2026 and deferment intimation dated April 20 2026 and in terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations) read with SEBI Master Circular No. HO/49/14/14(7)/2025-CFD-POD2/I/3762/2026 dated January 30 2026 we wish to inform you that the Meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as Covidh Technologies Limited) (the Company) was held today i.e. Tuesday April 21 2026 at the Registered Office of the Company situated at Office No. A1-1202 12th Floor Boulevard Tower Phase-2 CTS No. 11 Sadhu Vaswani Chowk Camp Pune - 411001 Maharashtra wherein the Board of Directors inter alia considered and approved the following matters:
4 months agoPursuant to our prior intimation dated April 15 2026 and deferment intimation dated April 20 2026 and in terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations) read with SEBI Master Circular No. HO/49/14/14(7)/2025-CFD-POD2/I/3762/2026 dated January 30 2026 we wish to inform you that the Meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as Covidh Technologies Limited) (the Company) was held today i.e. Tuesday April 21 2026 at the Registered Office of the Company situated at Office No. A1-1202 12th Floor Boulevard Tower Phase-2 CTS No. 11 Sadhu Vaswani Chowk Camp Pune - 411001 Maharashtra wherein the Board of Directors inter alia considered and approved the following matters:
4 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-10-24
Rights
25:1;10.0 (Rights ratio;Offer price)
Company details
Registered office
Office No. A1-1202, 12th Floor Boulevard Tower, Phase–2 C T S No. 11, Sadhu Vaswani Chowk, Camp Pune Maharashtra PIN: 411001 Tel No: 040-64643093 Fax No: 040-40266738 Email: [email protected] Internet: www.covidhtechnologies.com
Registrars
D-153/A, 1st Floor,Okhla Industrial Area, Phase - I, New Delhi - 110020 D-153/A, 1st Floor Okhla Industrial Area Phase - I PIN: Tel No: 91-011-26812682/84 Fax No: 91-11-26292681 Email: [email protected]
Management
Jayshree Suresh, Managing Director
Jitendra Prabhakar Nene, Executive Director
Mangina Srinivas Rao, Non Executive Independent Director
Rinku Saini, Non Executive Independent Director
Dhairyasheel Vasantrao Yadav, Non Executive Independent Director
Nandkumar Subhash Kadam, Executive Director
Pratap Dadasaheb Deshmukh, Non Independent & Non Executive Director
Ritu Dhanraj Garad, Non Executive Independent Director
Details
BSE 534920
NSE NULL
ISIN INE899M01020